Lesion-level effects of LDL-C-lowering therapy in patients with acute myocardial infarction.

A recent study published in Cardiovascular Week examined the effects of LDL-C-lowering therapy on patients with acute myocardial infarction. The study found that very intensive lipid-lowering therapy resulted in a significant reduction in atheroma volume at the lesion level. Additionally, treatment with alirocumab was associated with an increase in the minimum lumen area of the lesion and a transition from high-risk plaque phenotypes to more stable, less lipid-rich phenotypes. This research provides valuable insights into the potential benefits of aggressive lipid-lowering therapy for patients with heart disease. [Extracted from the article]

Copyright of Cardiovascular Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)